FAQ

Answers to the questions authors and readers ask most often about the Journal of Innovations in Pharmaceutical and Biological Sciences (JIPBS).

Is JIPBS indexed in Embase?

Yes. JIPBS (e-ISSN 2349-2759, p-ISSN 2395-1095) is listed as an active title in Elsevier's Embase journal list (October 2026 edition), published on Elsevier's Embase content page.

Is JIPBS an Elsevier journal?

No. JIPBS is published by Innovative Scientific Publishers. Embase is the biomedical database run by Elsevier, and JIPBS is one of the journals it indexes.

Which other databases index JIPBS?

Chemical Abstracts Service (CAS), a division of the American Chemical Society (CASSI record), and Google Scholar (profile). The full list is on the Indexing page.

What are the ISSNs and the DOI prefix of JIPBS?

e-ISSN 2349-2759 and p-ISSN 2395-1095. Articles receive Crossref DOIs with the prefix 10.56511.

Is JIPBS open access, and under which licence?

Yes. All articles are free to read online and are published under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International Licence (CC BY-NC-SA 4.0). See the Licensing and Copyright Policy.

How are manuscripts peer reviewed?

JIPBS uses double-blind peer review: the identities of authors and reviewers are withheld from one another. Each manuscript is first evaluated by the Editorial Board and then sent to reviewers. See the Peer Review Policy.

What does JIPBS publish?

Original research articles, reviews and mini-reviews, short communications and other article types across the pharmaceutical and biological sciences. See Aim and Scope and the Author Guidelines.

Is there a publication fee?

An Article Processing Charge applies only to accepted articles. The amounts are on the Publication Fees page, and waivers and discounts are explained in the Waiver and Discount Policy.

How do I submit a manuscript?

Read the Author Guidelines, then submit online through the journal's submission system.

How can I contact JIPBS?

Use the Contact page.